Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis
暂无分享,去创建一个
E. V. D. van der Vorst | Sanne L. Maas | Jules T. J. Teuwen | Emiel P. C. van der Vorst | Sanne L Maas
[1] M. Foretz,et al. The AMPK-related kinase NUAK1 controls cortical axons branching by locally modulating mitochondrial metabolic functions , 2024, Nature communications.
[2] I. Hanamura,et al. ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells , 2024, Cell death discovery.
[3] H. Hayashi,et al. AMPK activators suppress cholesterol accumulation in macrophages via suppression of the mTOR pathway. , 2023, Experimental cell research.
[4] Tudi Li,et al. LKB1 delays atherosclerosis by inhibiting phenotypic transformation of vascular smooth muscle cells. , 2023, International journal of cardiology.
[5] R. Dantzer,et al. Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition , 2023, Frontiers in cardiovascular medicine.
[6] D. Drewry,et al. How many kinases are druggable? A review of our current understanding , 2023, The Biochemical journal.
[7] Yue Wu,et al. Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6 , 2023, Cell death & disease.
[8] Saleha Anwar,et al. Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors. , 2023, ACS pharmacology & translational science.
[9] R. Roskoski. Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States , 2023, Pharmacological Research.
[10] H. Jo,et al. Flow-induced reprogramming of endothelial cells in atherosclerosis , 2023, Nature Reviews Cardiology.
[11] Sheyu Li,et al. Chloroquine Alleviates Atherosclerosis by Modulating Regulatory T Cells Through the ATM/AMPK/mTOR Signaling Pathway in ApoE −/− Mice , 2023, Experimental and Clinical Endocrinology & Diabetes.
[12] Shaoyi Zheng,et al. Macrophage polarization states in atherosclerosis , 2023, Frontiers in Immunology.
[13] B. Viollet,et al. Metformin: update on mechanisms of action and repurposing potential , 2023, Nature Reviews Endocrinology.
[14] R. Plummer,et al. A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer , 2023, British Journal of Cancer.
[15] Ana C. Henriques,et al. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence , 2023, Nature Cell Biology.
[16] D. Grobbee,et al. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. , 2023, The New England journal of medicine.
[17] Jared L. Johnson,et al. An atlas of substrate specificities for the human serine/threonine kinome , 2023, Nature.
[18] Matthew David Mulholland,et al. LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice , 2022, JACC. CardioOncology.
[19] P. Lei,et al. Mammalian Sterile 20-Like Kinase 1 Suppresses Atherosclerosis. , 2022, Circulation research.
[20] I. Vergote,et al. A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer. , 2022, Gynecologic oncology.
[21] Yang Zhou,et al. Metformin suppresses foam cell formation, inflammation and ferroptosis via the AMPK/ERK signaling pathway in ox‑LDL‑induced THP‑1 monocytes , 2022, Experimental and therapeutic medicine.
[22] R. Bast,et al. GRN300–001: Phase 1/1B evaluation of the safety, pharmacokinetics, and efficacy of GRN-300, a salt-inducible kinase inhibitor, alone and in combination with paclitaxel, in recurrent ovarian, primary peritoneal, and fallopian tube cancers. , 2022, Journal of Clinical Oncology.
[23] T. Hunter. A journey from phosphotyrosine to phosphohistidine and beyond. , 2022, Molecular cell.
[24] Peng Kong,et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention , 2022, Signal Transduction and Targeted Therapy.
[25] Mingming Sun,et al. GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2 , 2022, Clinical and translational medicine.
[26] G. Schernthaner,et al. Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. , 2022, Metabolism: clinical and experimental.
[27] W. Wahli,et al. Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue , 2021, Cells.
[28] G. Dimattia,et al. Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer , 2021, Scientific Reports.
[29] J. Hou,et al. Metformin inhibits cholesterol-induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells , 2021, Molecular medicine reports.
[30] Chao-ke Tang,et al. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis , 2021, Journal of cellular physiology.
[31] S. Matoba,et al. Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis , 2021, Scientific Reports.
[32] J. L. de la Pompa,et al. Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development , 2021, Arteriosclerosis, thrombosis, and vascular biology.
[33] J. Ji,et al. Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. , 2021, Free radical biology & medicine.
[34] Jae-Hoon Chang,et al. LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1 , 2021, Journal of Molecular Medicine.
[35] Q. Jiang,et al. Role of ARK5 in cancer and other diseases (Review) , 2021, Experimental and therapeutic medicine.
[36] Yufen Zhao,et al. Protein arginine phosphorylation in organisms. , 2021, International journal of biological macromolecules.
[37] Jiliang Wu,et al. Liver kinase B1 inhibits smooth muscle calcification via high mobility group box 1 , 2020, Redox biology.
[38] Derek J. Essegian,et al. The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer , 2020, Cell reports. Medicine.
[39] B. Viollet,et al. Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice , 2020, Journal of Lipid Research.
[40] Z. Chao,et al. The phosphorylation of CHK1 at Ser345 regulates the phenotypic switching of vascular smooth muscle cells both in vitro and in vivo. , 2020, Atherosclerosis.
[41] E. Latz,et al. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis , 2020, EBioMedicine.
[42] Hui Xu,et al. LKB1‐MARK2 signalling mediates lipopolysaccharide‐induced production of cytokines in mouse macrophages , 2020, Journal of cellular and molecular medicine.
[43] Q. Cui,et al. CD4+ T-Cell Endogenous Cystathionine γ Lyase–Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation , 2020, Circulation.
[44] Bo Yu,et al. Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway , 2020, Oxidative medicine and cellular longevity.
[45] A. F. Castro,et al. Cytosolic NUAK1 Enhances ATP Production by Maintaining Proper Glycolysis and Mitochondrial Function in Cancer Cells , 2020, Frontiers in Oncology.
[46] K. Moore,et al. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression , 2020, Circulation research.
[47] Zhi-guang Zhang,et al. Suberoylanilide Hydroxamic Acid Attenuates Interleukin-1β-Induced Interleukin-6 Upregulation by Inhibiting the Microtubule Affinity-Regulating Kinase 4/Nuclear Factor-κB Pathway in Synovium-Derived Mesenchymal Stem Cells from the Temporomandibular Joint , 2020, Inflammation.
[48] Nicole M. Chapman,et al. Signaling networks in immunometabolism , 2020, Cell Research.
[49] Sheng-Cai Lin,et al. AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control. , 2020, Cell metabolism.
[50] M. Zou,et al. Cardiomyocyte‐Specific Snrk Prevents Inflammation in the Heart , 2019, Journal of the American Heart Association.
[51] P. Libby,et al. Atherosclerosis , 2019, Nature Reviews Disease Primers.
[52] G. Zhong,et al. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages , 2019, The Journal of Immunology.
[53] Simin Liu,et al. Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue , 2019, Molecular metabolism.
[54] T. Sun,et al. LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy , 2019, Biological chemistry.
[55] M. Bennett,et al. Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.
[56] M. Clément,et al. MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[57] A. Waisman,et al. Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of Treg Cells. , 2019, Cell reports.
[58] Lei Zhang,et al. Metformin reduced NLRP3 inflammasome activity in Ox‐LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A , 2019, European journal of pharmacology.
[59] O. Soehnlein,et al. Myeloid-Specific Deletion of the AMPKα2 Subunit Alters Monocyte Protein Expression and Atherogenesis , 2019, International journal of molecular sciences.
[60] Ye Ding,et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis , 2019, Nature Communications.
[61] S. Allahverdian,et al. Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[62] B. Moran,et al. Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis , 2019, Front. Immunol..
[63] Peng Xu,et al. Conditional GWAS revealing genetic impacts of lifestyle behaviors on low-density lipoprotein (LDL) , 2019, Comput. Biol. Chem..
[64] Chunxiang Zhang,et al. PRKAA1/AMPKα1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis , 2018, Nature Communications.
[65] Jeremy D. Woods,et al. The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling , 2018, Science Translational Medicine.
[66] Hyun-A Seong,et al. Smad proteins differentially regulate obesity-induced glucose and lipid abnormalities and inflammation via class-specific control of AMPK-related kinase MPK38/MELK activity , 2018, Cell Death & Disease.
[67] Yun Zhang,et al. AMPKα inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2α/miRNA-124 axis , 2018, Journal of Molecular Medicine.
[68] Yaohui Nie,et al. Sucrose Nonfermenting-Related Kinase Regulates Both Adipose Inflammation and Energy Homeostasis in Mice and Humans , 2018, Diabetes.
[69] J. Jeng,et al. Lysophosphatidylcholine induces cytotoxicity/apoptosis and IL-8 production of human endothelial cells: Related mechanisms , 2017, Oncotarget.
[70] Yuehua Wu,et al. Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms , 2017, Cardiovascular Diabetology.
[71] Huaiping Zhu,et al. Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis , 2017, Circulation research.
[72] W. Xue,et al. NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. , 2017, Molecular cell.
[73] E. Ma,et al. AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species. , 2017, Cell reports.
[74] W. Guo,et al. Lkb1 maintains Treg cell lineage identity , 2017, Nature Communications.
[75] W. Liu,et al. C1q/TNF‐related protein 9 inhibits the cholesterol‐induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase , 2017, Journal of cellular and molecular medicine.
[76] Miao Zhang,et al. AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation , 2017, The Journal of Biological Chemistry.
[77] L. Birnbaumer,et al. Reduced Necrosis and Content of Apoptotic M1 Macrophages in Advanced Atherosclerotic Plaques of Mice With Macrophage-Specific Loss of Trpc3 , 2017, Scientific Reports.
[78] Hao Wu,et al. Eating the Dead to Keep Atherosclerosis at Bay , 2017, Front. Cardiovasc. Med..
[79] D. Greaves,et al. Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE−/− Reporter Mouse—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[80] Dongling Yang,et al. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis , 2017, Cell Research.
[81] J. Arthur,et al. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages , 2016, The Biochemical journal.
[82] J. Jeng,et al. 7-Ketocholesterol induces ATM/ATR, Chk1/Chk2, PI3K/Akt signalings, cytotoxicity and IL-8 production in endothelial cells , 2016, Oncotarget.
[83] Haibo Zhu,et al. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway. , 2016, Vascular pharmacology.
[84] Sheng-nan Wu,et al. Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In Vivo. , 2016, Circulation research.
[85] Miao Zhang,et al. AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability. , 2016, Circulation research.
[86] A. Ramne,et al. Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production , 2016, Diabetologia.
[87] C. Gilliéron,et al. SIK inhibition in human myeloid cells modulates TLR and IL‐1R signaling and induces an anti‐inflammatory phenotype , 2016, Journal of leukocyte biology.
[88] L. Gan,et al. Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes , 2016, Scientific Reports.
[89] B. Xue,et al. Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice , 2016, Diabetes.
[90] P. Loke,et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. , 2015, The Journal of clinical investigation.
[91] Cheng-Yi Kuo,et al. Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells , 2015, PloS one.
[92] Y. Liu,et al. Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells , 2015, Front. Pharmacol..
[93] L. Addadi,et al. ABCA1 contributes to macrophage deposition of extracellular cholesterol , 2015, Journal of Lipid Research.
[94] Laura S. Shankman,et al. KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.
[95] E. Tuzcu,et al. Cholesterol crystals associate with coronary plaque vulnerability in vivo. , 2015, Journal of the American College of Cardiology.
[96] Miao Zhang,et al. Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor κB (NF-κB) Activation in Macrophages* , 2014, The Journal of Biological Chemistry.
[97] L. Gan,et al. Mark4 promotes adipogenesis and triggers apoptosis in 3T3‐L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways , 2014, Biology of the cell.
[98] Daniel J. O'Connell,et al. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells , 2014, Proceedings of the National Academy of Sciences.
[99] Shan Yan,et al. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress , 2014, Cellular and Molecular Life Sciences.
[100] Dean Sheppard,et al. TGF-β activation and function in immunity. , 2014, Annual review of immunology.
[101] I. Rozenberg,et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. , 2014, European heart journal.
[102] Kwok-Kin Wong,et al. A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway , 2013, Nature Cell Biology.
[103] B. Viollet,et al. AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling , 2013, Journal of leukocyte biology.
[104] G. Rao,et al. The Transcription Factor CREB Enhances Interleukin-17A Production and Inflammation in a Mouse Model of Atherosclerosis , 2013, Science Signaling.
[105] R. Lister,et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK , 2013, Journal of Lipid Research.
[106] Yaohui Nie,et al. Identification of Sucrose Non-Fermenting–Related Kinase (SNRK) as a Suppressor of Adipocyte Inflammation , 2013, Diabetes.
[107] J. Dąbek,et al. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients. , 2013, Journal of postgraduate medicine.
[108] D. Hardie,et al. Metabolism of inflammation limited by AMPK and pseudo-starvation , 2013, Nature.
[109] M. McDevitt,et al. Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias , 2012, Clinical Cancer Research.
[110] J. Sznajder,et al. Salt‐inducible kinase 1 regulates E‐cadherin expression and intercellular junction stability , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[111] C. Heldin,et al. Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor β Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase* , 2012, The Journal of Biological Chemistry.
[112] D. Poulikakos,et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo , 2012, Nature Communications.
[113] Yuan Zhang,et al. AMP-Activated Protein Kinase Suppresses Endothelial Cell Inflammation Through Phosphorylation of Transcriptional Coactivator p300 , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[114] G. Rutter,et al. Human Mutation within Per-Arnt-Sim (PAS) Domain-containing Protein Kinase (PASK) Causes Basal Insulin Hypersecretion , 2011, The Journal of Biological Chemistry.
[115] Zuyi Yuan,et al. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. , 2011, Atherosclerosis.
[116] L. Yi,et al. Transcriptional regulation of Foxp3 in regulatory T cells. , 2011, Immunobiology.
[117] S. Girardin,et al. Mitochondrial ROS fuel the inflammasome , 2011, Cell Research.
[118] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[119] Soo-Ho Choi,et al. Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity , 2011, Circulation research.
[120] E. Mandelkow,et al. Structure and function of polarity‐inducing kinase family MARK/Par‐1 within the branch of AMPK/Snf1‐related kinases , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[121] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[122] H. Choi,et al. Reduction of AMP-Activated Protein Kinase &agr;2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo , 2010, Circulation.
[123] Axel Weber,et al. Interleukin-1 (IL-1) Pathway , 2010, Science Signaling.
[124] T. Asano,et al. Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation* , 2009, The Journal of Biological Chemistry.
[125] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[126] D. Teupser,et al. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. , 2008, Atherosclerosis.
[127] J. Yates,et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.
[128] P. Teeling,et al. Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.
[129] M. Okamoto,et al. TORC‐SIK cascade regulates CREB activity through the basic leucine zipper domain , 2007, The FEBS journal.
[130] J. Mehta,et al. Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet , 2007, Circulation research.
[131] G. Fantuzzi,et al. Adipose Tissue and Atherosclerosis: Exploring the Connection , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[132] M. Bennett,et al. DNA damage and repair in atherosclerosis. , 2006, Cardiovascular research.
[133] Melanie Lukasser,et al. Atherosclerosis research from past to present—on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow , 2006, Virchows Archiv.
[134] E. Raines,et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. , 2005, The Journal of clinical investigation.
[135] M. Bollen,et al. Substrate Specificity and Activity Regulation of Protein Kinase MELK* , 2005, Journal of Biological Chemistry.
[136] David P. Davis,et al. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. , 2005, Cancer research.
[137] D. Alessi,et al. Identification of the sucrose non‐fermenting related kinase SNRK, as a novel LKB1 substrate , 2005, FEBS letters.
[138] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[139] M. Bollen,et al. Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1* , 2004, Journal of Biological Chemistry.
[140] Jérôme Boudeau,et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.
[141] B. Kemp. Faculty Opinions recommendation of Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. , 2003 .
[142] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[143] J. Mehta,et al. Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1 , 2002, Journal of Pharmacology and Experimental Therapeutics.
[144] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[145] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[146] P. Cohen,et al. The origins of protein phosphorylation , 2002, Nature Cell Biology.
[147] K. Alitalo,et al. Vascular Abnormalities and Deregulation of VEGF in Lkb1-Deficient Mice , 2001, Science.
[148] G. D. De Meyer,et al. Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering , 2001, Circulation research.
[149] Y. A. Minamishima,et al. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.
[150] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[151] B. Kemp,et al. Non-catalytic - and -Subunit Isoforms of the 5′-AMP-activated Protein Kinase (*) , 1996, The Journal of Biological Chemistry.
[152] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[153] R. Wootton,et al. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[154] R. Dean,et al. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. , 1992, Biochimica et biophysica acta.
[155] P. Libby,et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[156] U. Steinbrecher,et al. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. , 1991, The Journal of biological chemistry.
[157] J L Witztum,et al. Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.
[158] F. Parhami,et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[159] T. Carew,et al. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. , 1989, Arteriosclerosis.
[160] Manning Feinleib,et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.
[161] F. Rovelli. [The European Society of Cardiology]. , 1978, Giornale italiano di cardiologia.
[162] R. Schroter,et al. Arterial Wall Shear and Distribution of Early Atheroma in Man , 1969, Nature.
[163] A. Orekhov,et al. CD68/macrosialin: not just a histochemical marker , 2017, Laboratory Investigation.
[164] C. Gleissner,et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability , 2010, Basic Research in Cardiology.
[165] Richard J. Shaw. Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress , 2004 .
[166] Bruce Alberts,et al. General Principles of Cell Communication , 2002 .
[167] T. Hunter,et al. Protein kinase classification. , 1991, Methods in enzymology.
[168] BHF Fundraising,et al. The British Heart Foundation , 1963, Nature.